Announcement PDF ASX ANNOUNCEMENT 2 July 2024 Notice Under Section 708A(5) of the Corporations Act 2001 This notice is given by Radiopharm Theranostics Limited (ASX:RAD) (‘RAD’ or the ‘Company’) under section 708A(5)(e) of the Corporations Act 2001 (the ‘Corporations Act’). Type Shares Class/description Ordinary Fully Paid ASX code RAD Date of issue 1 July 2024 Number issued 597,130,727 The Company gives notice under section 708A(5)(e) of the Corporations that: 1. the Company issued the Shares without disclosure under Part 6D.2 of the Corporations Act; 2. as at the date of this notice the Company has complied with: (i) the provisions of Chapter 2M of the Corporations Act as they apply to the Company; and (ii) 3. sections 674 and 674A of the Corporations Act; and as at the date of this notice, there is no information to be disclosed which is ‘excluded information’ (as defined in sections 708A(7) and 708A(8) of the Corporations Act) which is required to be disclosed by the Company. Nathan Jong Joint Company Secretary Radiopharm Theranostics Limited Suite 1, Level 3, 62 Lygon Street, Carlton South VIC 3053 Australia ABN: 57 647 877 889